Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), Diamines and Chemicals has informed that the Company has received a Trading approval for 2,69,402 Equity shares allotted pursuant to conversion of warrants issued on preferential basis from National Stock Exchange India (‘NSE’) via letter bearing no. NSE/LIST/ 55629 dated June 11, 2026 and from BSE via letter bearing no. LOD / PREF / SV / 247/ 2026-2027 dated June 11, 2026. The above equity shares of the Company are listed and admitted to dealings on the Exchange from June 12, 2026. In respect of the above, additional disclosures as required under SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, for Granting, withdrawal, surrender, cancellation or suspension of key licenses or regulatory approvals are provided at ‘Annexure A’. The company has enclosed the Trading Approval Letter received from NSE and BSE.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| SRF | 2738.40 |
| BASF India | 3352.95 |
| Tata Chemicals | 746.60 |
| Pidilite Inds. | 1536.00 |
| Deepak Nitrite | 1670.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: